Sign in / Join Now
ETFs & Funds
- Medical Key Opinion Leaders in Preeclampsia Join Pluristem's Steering Committee
Add a reply...
Latest StockTalks »
people get PSTI breaking news and analysis by email alert.
Get email alerts on PSTI »
Pluristem Therapeutics, Inc.
Get latest price
From other sites
Pluristem Increases Previously Announced Bought Deal Offering Of Common Stock And Warrants To $15,000,000
at TheStreet (Fri, 7:00AM)
Pluristem Announces Bought Deal Offering
at TheStreet (Thu, 4:53PM)
Pluristem Receives Clearance From Germany To Initiate Its Multinational Phase III Trial In Critical Limb Ischemia Targeting Early Conditional Marketing Approval
at TheStreet (Tue, 5:30AM)
Pluristem Completes Patient Enrollment In A Large Multinational Phase II Trial In Intermittent Claudication
at TheStreet (Jan 12, 2017)
Pluristem's Phase III Study Of PLX-PAD Cells For The Treatment Of Critical Limb Ischemia Cleared By U.S. FDA
at TheStreet (Jan 10, 2017)